Parent Training for Disruptive Behavior

To access the video vignettes, please visit oup.com/RUBI

Autism spectrum disorder (ASD) involves difficulties in social interaction and communication, restricted interests and repetitive behavior. Approximately half of children with ASD also exhibit disruptive behaviors such as tantrums and aggression, which can be stressful for the child and family.

Parent Training for Disruptive Behavior is an 11 session intervention for parents who wish to learn how to reduce disruptive behaviors and increase adaptive skills in their children with ASD. Each session introduces effective behavior change strategies and includes easy to use worksheets, checklists, and take home activities to help parents apply what they have learned. By participating in this intervention with a trained therapist, parents can help their children overcome behavior problems, promoting happier kids and families.

Karen Bearss, PhD is Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. Dr. Bearss specializes in the assessment and treatment of individuals with Autism Spectrum Disorder (ASD) and their families. Her current research focus is in developing, implementing, and evaluating evidence-based parenting interventions for children with Autism Spectrum Disorders (ASD). She is also invested in designing strategies for improving the dissemination and implementation of evidence-based treatments into the community.

Cynthia R. Johnson, PhD is the Director of the Cleveland Clinic Center for Autism and faculty of the Lerner College of Medicine, Case Western Reserve University. She is currently the principal investigator of a NIH-funded grant studying the efficacy of parent training in the treatment of feeding problems. She has had prior NIH funding on the efficacy of parent training in the treatment of disruptive behaviors in young children with Autism Spectrum Disorder and the treatment of sleep disturbances. Dr. Johnson is a licensed psychologist and a board-certified behavior analyst- doctoral level.

Benjamin Handen, PhD is Professor of Psychiatry and Pediatrics at the University of Pittsburgh School of Medicine and principal investigator of the University of Pittsburgh Autism Treatment Network (ATN). Over the past 30 years, Dr. Handen has led a number of federally-funded and foundation-funded studies involving both children and adults with autism spectrum disorder. His research has focused on both pharmacological and psychosocial interventions. He is a licensed psychologist and board-certified behavior analyst-doctoral level.

Eric M. Butter, PhD is an Associate Professor of Pediatrics and Psychology at the Ohio State University and Chief of Pediatric Psychology and Neuropsychology at Nationwide Children's Hospital in Columbus, Ohio, where is also the Director of the Child Development Center. Dr. Butter is a Clinical Psychologist with specialization in autism spectrum disorder and other neurodevelopmental disabilities and his research has focused on the bio-medical correlates, potential etiologies and treatment of these disorders.

Luc Lecavalier, PhD, is a Professor of Psychology and Psychiatry at The Ohio State University. He is a clinical psychologist who is interested in the assessment and treatment of individuals with autism spectrum disorder and other neurodevelopmental disabilities. He has authored or co-authored more than 100 publications on the topic.

Tristram Smith, PhD, is the Haggerty-Friedman Professor of Developmental/Behavioral Pediatric Research at the University of Rochester Medical Center (URMC), where he leads federally funded studies comparing the efficacy of different interventions for children with autism spectrum disorder. He is also a clinician in URMC's Community Consultation Program, serving students with ASD and other intellectual disabilities in schools and other agencies.

Lawrence Scahill, MSN, PhD, is Professor of Pediatrics at Emory University School of Medicine and Director of Clinical Trials at the Marcus Autism Center. He has played a central role in the Research Units on Pediatric Psychopharmacology (RUPP) Autism Network and the Research Units on Behavioral Intervention (RUBI).